<p><b>A</b>, Mice were treated with Poly I:C (1.5 µg per mouse, i.v.) together with D-GalN (10 mg per mouse, i.p.); and then euthanized at 2h, 4h, 6h, 8h, 12h, 18h, 24h, 48h time points post Poly I:C/D-GalN treatment. The expression of CRACC mRNA was assayed by quantitative PCR (upper panel); and the serum ALT was tested (lower panel). <b>B</b>, Mice were treated with saline alone, Poly I:C alone, D-GalN alone or Poly I:C together with D-GalN for 12h; and then the CRACC expression on Kupffer cells and hepatic NK cells was analyzed by flow cytometry. Kupffer cells were identified as F4/80<sup>+</sup> cells and NK cells were identified as NK1.1 <sup>+</sup> CD3<sup>-</sup> cells. Data are from 6-9 mice per group.</p
<p><b>A</b>, Ana-1 cells pre-transfected with liposome encapsulated siNeg or siCRACC was subsequentl...
<p>TNF-α<sup>+/+</sup> and TNF-α<sup>−/−</sup> mice were treated with or without GalN (20 mg) and su...
<p>(A–F) C3aR antagonist group mice displayed reduced liver damage (A–B, D–E) and decreased C3 depos...
<p><b>A</b>-<b>C</b>, Mice were treated with nanoparticle encapsulated FAM conjunct siRNA by intrave...
<p>Poly I:C stimulation (<b>A</b>) elevated the CARCC expression on NK cells and resident Kupffer ce...
<p>CRACC expression on NK cells (solid line) and NKT cells (long dashed line) from mice treated with...
<div><p>CD2-like receptor activating cytotoxic cells (CRACC) is known as a critical activating recep...
<p>(<b>A</b>) Pre-depletion (48h before) of NK cells by anti-ASGM1 antibody in mice and confirmation...
<p>(<b>A</b>) Levels of serum AST/ALT (IU/L) in WT and CD1d KO mice following PBS, Poly(I:C) (30 µg/...
<p>CRACC expression on alveolar Mϕ, peritoneal Mϕ and Kupffer cells from mice treated with Poly I:C ...
<p>(A) TRAIL<sup>+</sup> NK cell numbers did not increase in hepatectomized mice after poly I:C trea...
<p>Wt C57BL/6 mice and C3<sup>−/−</sup> mice were injected with LPS/D-GalN i.p. and euthanized at 0,...
<p>(<b>A</b>) Levels of serum AST/ALT (IU/L) and relative fold change in mRNA expression of IL-33 in...
<p>Relative fold change in mRNA expression of TNF-α, IL-1β, IL-6, TRAIL, CXCL1, and IFN-γ in livers ...
OBJECTIVE: To investigate the effects of an intradermal injection of oligodeoxynucleotides (ODNs) co...
<p><b>A</b>, Ana-1 cells pre-transfected with liposome encapsulated siNeg or siCRACC was subsequentl...
<p>TNF-α<sup>+/+</sup> and TNF-α<sup>−/−</sup> mice were treated with or without GalN (20 mg) and su...
<p>(A–F) C3aR antagonist group mice displayed reduced liver damage (A–B, D–E) and decreased C3 depos...
<p><b>A</b>-<b>C</b>, Mice were treated with nanoparticle encapsulated FAM conjunct siRNA by intrave...
<p>Poly I:C stimulation (<b>A</b>) elevated the CARCC expression on NK cells and resident Kupffer ce...
<p>CRACC expression on NK cells (solid line) and NKT cells (long dashed line) from mice treated with...
<div><p>CD2-like receptor activating cytotoxic cells (CRACC) is known as a critical activating recep...
<p>(<b>A</b>) Pre-depletion (48h before) of NK cells by anti-ASGM1 antibody in mice and confirmation...
<p>(<b>A</b>) Levels of serum AST/ALT (IU/L) in WT and CD1d KO mice following PBS, Poly(I:C) (30 µg/...
<p>CRACC expression on alveolar Mϕ, peritoneal Mϕ and Kupffer cells from mice treated with Poly I:C ...
<p>(A) TRAIL<sup>+</sup> NK cell numbers did not increase in hepatectomized mice after poly I:C trea...
<p>Wt C57BL/6 mice and C3<sup>−/−</sup> mice were injected with LPS/D-GalN i.p. and euthanized at 0,...
<p>(<b>A</b>) Levels of serum AST/ALT (IU/L) and relative fold change in mRNA expression of IL-33 in...
<p>Relative fold change in mRNA expression of TNF-α, IL-1β, IL-6, TRAIL, CXCL1, and IFN-γ in livers ...
OBJECTIVE: To investigate the effects of an intradermal injection of oligodeoxynucleotides (ODNs) co...
<p><b>A</b>, Ana-1 cells pre-transfected with liposome encapsulated siNeg or siCRACC was subsequentl...
<p>TNF-α<sup>+/+</sup> and TNF-α<sup>−/−</sup> mice were treated with or without GalN (20 mg) and su...
<p>(A–F) C3aR antagonist group mice displayed reduced liver damage (A–B, D–E) and decreased C3 depos...